Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Completion pneumonectomy: experience in eighty patients.

J F Regnard1, P Icard, P Magdeleinat

  • 1Department of Thoracic Surgery, Marie Lannelongue Hospital, Le Plessis Robinson, France.

The Journal of Thoracic and Cardiovascular Surgery
|May 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Encephalopathy and seizure activity in a COVID-19 well controlled HIV patient.

IDCases·2020
Same author

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT.

Bone marrow transplantation·2017
Same author

How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

Oncogene·2014
Same author

Mediastinal recurrence from ovarian cystadenocarcinoma presenting as pleuro-pericardial cyst.

European review for medical and pharmacological sciences·2014
Same author

Systematic lymph node dissection in lung metastasectomy of renal cell carcinoma: an 18 years of experience.

Journal of surgical oncology·2014
Same author

Fully endoscopic major pulmonary resection for stage I bronchial carcinoma: initial results.

Revue des maladies respiratoires·2011
Same journal

Bridging Pediatric and Young Adult Cancer Survivorship: Defining the Thoracic Surgeon's Role Across the Continuum.

The Journal of thoracic and cardiovascular surgery·2026
Same journal

Beyond compensatory expansion: Extending 3-dimensional computed tomography volumetry toward lung-preserving local therapy.

The Journal of thoracic and cardiovascular surgery·2026
Same journal

A CALL FOR STANDARDIZATION OF HYBRID ARCH FROZEN ELEPHANT TRUNK OUTCOMES REPORTING.

The Journal of thoracic and cardiovascular surgery·2026
Same journal

Pediatric Mitral Valve Surgery: Current Practice from the European Congenital Heart Surgeons Association Congenital Database Analysis.

The Journal of thoracic and cardiovascular surgery·2026
Same journal

Rethinking Failure to Rescue in Cardiac Surgery.

The Journal of thoracic and cardiovascular surgery·2026
Same journal

Undersized Fontan conduits are not without risk.

The Journal of thoracic and cardiovascular surgery·2026
See all related articles

Completion pneumonectomy offers a second chance for cure in lung cancer patients with acceptable mortality. However, patients previously irradiated or treated for infectious benign disease face higher risks of postoperative complications.

Area of Science:

  • Thoracic Surgery
  • Surgical Oncology
  • Pulmonary Medicine

Background:

  • Completion pneumonectomy is a complex procedure with perceived risks.
  • Understanding factors influencing outcomes is crucial for patient management.

Purpose of the Study:

  • To identify factors affecting complications and survival after completion pneumonectomy.
  • To evaluate the safety and efficacy of this procedure.

Main Methods:

  • Retrospective review of 80 completion pneumonectomies over 25 years.
  • Analysis of patient data including disease type, stage, prior treatments, and outcomes.

Main Results:

  • Overall postoperative mortality was 5%, with 0% for benign disease and 6.4% for cancer.

Related Experiment Videos

  • Previous irradiation and treatment for infectious benign disease increased risk of empyema and fistula.
  • Actuarial 5-year survival for lung cancer was 36%, with better outcomes for earlier stages (Stage I: 51%, Stage II: 42%).

    • Conclusions:

    • Completion pneumonectomy is a viable option with acceptable mortality, providing a potential cure for cancer patients.
    • Identifying high-risk patient groups (previously irradiated, infectious benign disease) allows for targeted management to mitigate complications.